These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 10612586

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Monocharged inhibitors of mast cell tryptase derived from potent and selective dibasic inhibitors.
    Dener JM, Wang VR, Rice KD, Gangloff AR, Kuo EY, Newcomb WS, Putnam D, Wong M.
    Bioorg Med Chem Lett; 2001 Sep 03; 11(17):2325-30. PubMed ID: 11527724
    [Abstract] [Full Text] [Related]

  • 3. Novel pyrazinone inhibitors of mast cell tryptase: synthesis and SAR evaluation.
    Hopkins C, Neuenschwander K, Scotese A, Jackson S, Nieduzak T, Pauls H, Liang G, Sides K, Cramer D, Cairns J, Maignan S, Mathieu M.
    Bioorg Med Chem Lett; 2004 Oct 04; 14(19):4819-23. PubMed ID: 15341931
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Synthesis and evaluation of diphenyl phosphonate esters as inhibitors of the trypsin-like granzymes A and K and mast cell tryptase.
    Jackson DS, Fraser SA, Ni LM, Kam CM, Winkler U, Johnson DA, Froelich CJ, Hudig D, Powers JC.
    J Med Chem; 1998 Jun 18; 41(13):2289-301. PubMed ID: 9632362
    [Abstract] [Full Text] [Related]

  • 8. Bis(5-amidino-2-benzimidazolyl)methane and related amidines are potent, reversible inhibitors of mast cell tryptases.
    Caughey GH, Raymond WW, Bacci E, Lombardy RJ, Tidwell RR.
    J Pharmacol Exp Ther; 1993 Feb 18; 264(2):676-82. PubMed ID: 8437115
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. kynapcin-13 and -28, new benzofuran prolyl endopeptidase inhibitors from polyozellus multiplex.
    Kim SI, Park IH, Song KS.
    J Antibiot (Tokyo); 2002 Jul 18; 55(7):623-8. PubMed ID: 12243451
    [Abstract] [Full Text] [Related]

  • 12. Dibasic inhibitors of human mast cell tryptase. Part 1: synthesis and optimization of a novel class of inhibitors.
    Rice KD, Gangloff AR, Kuo EY, Dener JM, Wang VR, Lum R, Newcomb WS, Havel C, Putnam D, Cregar L, Wong M, Warne RL.
    Bioorg Med Chem Lett; 2000 Oct 16; 10(20):2357-60. PubMed ID: 11055355
    [Abstract] [Full Text] [Related]

  • 13. Structure-activity relationship studies of chloromethyl ketone derivatives for selective human chymase inhibitors.
    Hayashi Y, Iijima K, Katada J, Kiso Y.
    Bioorg Med Chem Lett; 2000 Feb 07; 10(3):199-201. PubMed ID: 10698435
    [Abstract] [Full Text] [Related]

  • 14. 1,2-Benzisothiazol-3-one 1,1-dioxide inhibitors of human mast cell tryptase.
    Combrink KD, Gülgeze HB, Meanwell NA, Pearce BC, Zulan P, Bisacchi GS, Roberts DG, Stanley P, Seiler SM.
    J Med Chem; 1998 Nov 19; 41(24):4854-60. PubMed ID: 9822554
    [Abstract] [Full Text] [Related]

  • 15. Neutrophil myeloperoxidase is a potent and selective inhibitor of mast cell tryptase.
    Cregar L, Elrod KC, Putnam D, Moore WR.
    Arch Biochem Biophys; 1999 Jun 01; 366(1):125-30. PubMed ID: 10334872
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of human mast cell tryptase by benzamidine derivatives.
    Stürzebecher J, Prasa D, Sommerhoff CP.
    Biol Chem Hoppe Seyler; 1992 Oct 01; 373(10):1025-30. PubMed ID: 1418674
    [Abstract] [Full Text] [Related]

  • 17. Structure based design of 4-(3-aminomethylphenyl)piperidinyl-1-amides: novel, potent, selective, and orally bioavailable inhibitors of betaII tryptase.
    Levell J, Astles P, Eastwood P, Cairns J, Houille O, Aldous S, Merriman G, Whiteley B, Pribish J, Czekaj M, Liang G, Maignan S, Guilloteau JP, Dupuy A, Davidson J, Harrison T, Morley A, Watson S, Fenton G, McCarthy C, Romano J, Mathew R, Engers D, Gardyan M, Sides K, Kwong J, Tsay J, Rebello S, Shen L, Wang J, Luo Y, Giardino O, Lim HK, Smith K, Pauls H.
    Bioorg Med Chem; 2005 Apr 15; 13(8):2859-72. PubMed ID: 15781396
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of human beta-tryptase by Bowman-Birk inhibitor derived peptides: creation of a new tri-functional inhibitor.
    Scarpi D, McBride JD, Leatherbarrow RJ.
    Bioorg Med Chem; 2004 Dec 01; 12(23):6045-52. PubMed ID: 15519150
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Design, synthesis and pharmacological evaluation of 3-benzylazetidine-2-one-based human chymase inhibitors.
    Aoyama Y, Uenaka M, Kii M, Tanaka M, Konoike T, Hayasaki-Kajiwara Y, Naya N, Nakajima M.
    Bioorg Med Chem; 2001 Nov 01; 9(11):3065-75. PubMed ID: 11597491
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.